Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Northstar Gold Signs MOU with Hunan Nonferrous Ltd. to Develop Gold Resource (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Chemicals Specialty Chemicals
Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Ceapro Inc > PGX plans
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(113)
•••
Comment by prophetoffactzon Jan 10, 2024 1:36pm
104 Views
Post# 35819789

RE:PGX plans

RE:PGX plans
lscfa wrote:

Gagnon needs to disclose in writing the economics of PGX plant if he wants shareholders on board. Not some off the cuff comment in a obscure video.


e.g. 




https://www.globenewswire.com/news-release/2024/01/10/2807020/0/en/Internal-Technical-and-Economic-Study-Indicates-HPQ-Fumed-Silica-Reactor-s-Robust-Potential-at-Commercial-Scale.html



It has been early stage and putting all of your jewely out on the table in the public market isn't without risks. We've never seen any preclinical avenanthramide data either. CZO has been working within cash to key milestones. It's played its cards close to its chest. The commissioning of the 5X and 10X scale-up with a partner will tell the PGX story as CZO also potentially announces an immune booster plant. The avenanthramide safety/tolerability and efficacy data will hit soon enough too. Then the world will know by how much this little, secretive company is onto something. Gilles wants on NASDAQ so that may be a strong hint of what it expects to happen next as it also tries to add AEZS's capital to its growth plan. 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities